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ABSTRACT: The anophelins are small protein thrombin inhibitors that
are produced in the salivary glands of the Anopheles mosquito to fulﬁll a vital
role in blood feeding. A bioinformatic analysis of anophelin sequences
revealed the presence of conserved tyrosine residues in an acidic
environment that were predicted to be post-translationally sulfated in vivo.
To test this prediction, insect cell expression of two anophelin proteins,
from Anopheles albimanus and Anopheles gambiae, was performed, followed
by analysis by mass spectrometry, which showed heterogeneous sulfation at
the predicted sites. Homogeneously sulfated variants of the two proteins
were subsequently generated by chemical synthesis via a one-pot ligation−
desulfurization strategy. Tyrosine sulfation of the anophelins was shown to
signiﬁcantly enhance the thrombin inhibitory activity, with a doubly sulfated
variant of the anophelin from A. albimanus exhibiting a 100-fold increase in
potency compared with the unmodiﬁed homologue. Sulfated anophelins were also shown to exhibit potent in vivo anticoagulant
and antithrombotic activity.
■ INTRODUCTION
Hematophagous invertebrates have evolved highly eﬀective
mechanisms to facilitate the acquisition of a blood meal via the
production of exquisitely potent and selective inhibitors of host
coagulation factors, in particular the serine proteinase
thrombin.1,2 These organism-evolved molecules have been
reported to possess reduced toxicity and immunogenicity,
privileged properties that are often diﬃcult to design or predict
in small-molecule thrombin inhibitors. It is therefore not
surprising that molecules derived from blood feeding organisms
have found utility in therapy, with the archetypal anticoagulant
hirudin (from the medicinal leech Hirudo medicinalis) and
structural analogues of this protein being used clinically for a
range of thromboembolic disorders and postsurgery.3
One feature of these natural thrombin-inhibiting molecules
that is often overlooked is the potential presence of post-
translational modiﬁcations and the eﬀect that these may have
on the activity and/or stability of the native peptides and
proteins. Interestingly, despite the fact that recombinant
hirudin used clinically does not bear any modiﬁcations, the
native leech protein was ﬁrst identiﬁed with a tyrosine sulfate
modiﬁcation, which was shown to impart a ca. 10-fold
improvement in thrombin inhibitory activity.4 We have recently
discovered an important role of tyrosine sulfation for the
thrombin inhibitory activity of two saliva-derived thrombin
inhibitors, madanin-1 and chimadanin, from the bush tick
Haemaphysalis longicornis.5 These two inhibitors were shown to
exert their activity by binding to the active site and exosite II of
human thrombin, with sulfation at two conserved tyrosine
residues providing signiﬁcant improvement in the thrombin
inhibitory activity. This improved potency was attributed to
enhanced binding of the inhibitor to exosite II of thrombin
mediated by electrostatic interactions between the sulfated
tyrosine residues and conserved basic residues on the enzyme,
as identiﬁed through X-ray crystallography.5 On the basis of
these ﬁndings, we now hypothesize that tyrosine sulfation could
be a ubiquitous modiﬁcation of salivary proteins from other
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hematophagous organisms that could serve as a general
mechanism for modulating anticoagulant activity during
feeding.
The anophelins are an interesting family of thrombin-
inhibiting proteins produced in the salivary glands of the
Anopheles malaria mosquito vector.6,7 To date, the genomes of
16 Anopheles mosquitoes have been reported (Figure 1),8
leading to the identiﬁcation of a number of anophelin protein
homologues in “old-world” mosquitoes, e.g., Anopheles funestus,
Anopheles gambiae, and Anopheles stephensi, as well as “new-
world” mosquitoes such as Anopheles albimanus and Anopheles
darlingi.6,7 Anophelin proteins that are recombinantly expressed
in Escherichia coli have previously been shown to exhibit potent
inhibitory activity against human thrombin via a binding mode
distinct from that of other proteinaceous thrombin inhibitors
that have been identiﬁed to date. In contrast to hirudin, where
the N-terminus blocks the active site of thrombin and the C-
terminus binds to exosite I, the anophelins bind in the opposite
orientation, with the C-terminal portion occupying the active
site (thus disrupting the catalytic triad) while the N-terminus
extends onto exosite I.6,9 Guided by sequence analysis of a
number of other peptides and proteins that are known to be
post-translationally sulfated, we used a bioinformatics approach
to predict that each of the proteins within the anophelin family
possessed one or two conserved tyrosine residues that would be
candidates for sulfation by tyrosylprotein sulfotransferase
(TPST) enzymes in vivo. Speciﬁcally, the anophelins possess
conserved tyrosine residues embedded within highly acidic
stretches within their amino acid sequences, which is a
predictor for post-translational sulfation by TPSTs.10−13
While to date tyrosine sulfation has not been suggested or
identiﬁed as a modiﬁcation of mosquito salivary proteins, this
analysis provided the impetus to test the hypothesis that the
anophelins are natively sulfated and that this modiﬁcation
would directly aﬀect the inhibitory activity of the proteins
against thrombin. To test this hypothesis, we chose to
investigate an “old-world” mosquito and a “new-world”
mosquito as examples in order to probe the eﬀect of tyrosine
sulfation on the inhibition of thrombin by the family of
anophelin proteins. For this purpose, we selected anophelins
from A. gambiae and A. albimanus (herein denoted as AAg and
AAa, respectively) that exhibited the most potent inhibition of
thrombin in unmodiﬁed recombinant form from each family.6
In this study, we demonstrate that sulfation of AAa and AAg
occurs in insect cells (by baculovirus-assisted recombinant
expression) at the sites predicted in our bioinformatics analysis.
We also demonstrate an eﬃcient synthetic method to access
homogeneously sulfated AAa and AAg through the use of
ligation−desulfurization chemistry. Importantly, these synthetic
sulfoproteins were shown to be signiﬁcantly more potent
thrombin inhibitors than the unmodiﬁed counterparts and
possessed potent antithrombotic activity in an in vivo
thrombosis model.
■ RESULTS
Anophelins Are Sulfated in Insect Cells. Access to
homogeneous samples of post-translationally modiﬁed proteins
is challenging, as extremely low quantities of the proteins can
typically be isolated from the natural source, in this case the
salivary glands of the Anopheles mosquito. Typical prokaryotic
expression systems lack the TPST enzymatic machinery to
generate appropriately post-translationally modiﬁed mole-
cules.13 Therefore, we ﬁrst expressed AAa and AAg in a
eukaryotic system to investigate whether the proteins could
be sulfated in vivo. For this purpose, we used Trichoplusia ni
insect cells as a model of the Anopheles mosquito. Speciﬁcally,
codon-optimized sequences encoding AAa and AAg were
designed as N-terminal fusions with the honeybee mellitin
signal sequence in order to direct the recombinant proteins to
the secretory pathway. Following expression, the cell medium
containing the secreted proteins was analyzed by nanoliquid
chromatography coupled to tandem mass spectrometry
(nanoLC−MS/MS). Analysis of insect-cell-expressed AAa
showed a heterogeneous population of sulfated protein with
approximately 0.8% monosulfated and 41% disulfated variants
(see Figure 2A and the Supporting Information, Table 1). MS/
MS analysis of full length AAa with complementary
fragmentation approaches, including higher-collisional dissoci-
ation (HCD) and electron transfer dissociation (ETD),
conﬁrmed the presence of sulfation via neutral loss but was
unable to localize the sites of modiﬁcation (Figure 2B). A
tryptic digest of AAa revealed an N-terminal trypsin fragment
Figure 1. Sequence alignment of members of the anophelin family showing strictly conserved residues (salmon), widely conserved amino acids
(purple), conserved residues in the “new-world” (red) or “old-world” (yellow) anophelins, and potential sulfated tyrosine (Tyr or Y) sites (black).6
NB: The C-terminal sulfation site (position 34 in AAa) is not strictly conserved and a negatively charged glutamate residue can instead be found at
this position in anophelins from old-world mosquitoes.6
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(APQYAPGDEPSYDEDTDDSDK) possessing two tyrosine
residues (Tyr4 and Tyr12, underlined) in addition to a second
fragment (LVENDTSITDEDYAAIEASLSETFNTAADPGR)
containing a single tyrosine residue (Tyr34, underlined)
(Figure 2C). In order to pinpoint the site of sulfation, we
synthesized two monosulfated tryptic peptides with sulfation at
Tyr4 and Tyr12 (see the Supporting Information). By
comparing the retention time to those of the trypsinized
fragments from the insect cell expression, we were able to
demonstrate that Tyr12 was (as predicted) the site of sulfation
on AAa (Figure 2D). Analysis of the medium from the AAg
expression by nanoLC−MS revealed a heterogeneous mixture
of a protein with approximately 20% monosulfation together
with the unsulfated form, which was conﬁrmed by MS/MS
analysis (see Figure 2F,G and the Supporting Information,
Table 2). It should be noted that in the case of AAg a glutamate
residue is found in the position equivalent to Tyr34 in AAa,
similar to many other anophelins from old-world mosquitoes
(Figure 1), precluding the possibility of sulfation at this site. As
with AAa, two tyrosine residues (Tyr4 and Tyr12) are present
within the N-terminal region, but the presence of Arg at
position 6 of this protein enabled the generation of two tryptic
Figure 2. Analysis of AAa and AAg produced in Trichoplusia ni insect cells by nanoLC−MS/MS. (A) [M + 5H]5+ extracted ion chromatograms and
average precursor MS1 spectrum of full-length AAa in the unmodiﬁed, mono-, and disulfated isoforms. (B) HCD MS/MS of disulfated AAa [M + 5H
+ 2SO3]
5+. (C) In silico tryptic digestion of AAa highlighting the potential sites of tyrosine sulfation. (D) Extracted ion chromatograms of synthetic
and trypsin-digested monosulfated peptide APQYAPGDEPSYDEDTDDSDK of AAa. (E) EThcD MS/MS of the monosulfated peptide
LVENDTSITDEDYAAIEASLSETFNTAADPGR of AAa. (F) [M + 8H]8+ extracted ion chromatograms and average precursor MS1 spectrum of full-
length AAg in the unmodiﬁed and monosulfated isoforms. (G) HCD MS/MS of disulfated AAg [M + 8H + 2SO3]
8+. (H) In silico tryptic digestion of
AAg highlighting the potential sites of tyrosine sulfation. (I) EThcD MS/MS of the monosulfated peptide GDVPTYDEEDFDEESLKPH of AAg (*
indicates ions that contain SO3
−).
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peptides in addition to minor amounts of an endogenous
cleavage event at His25 (Figure 2H). MS/MS analysis of the
fragment GVDPTYDEEDFDEESLKPH conﬁrmed the pres-
ence of sulfation and was able to unequivocally localize the
modiﬁcation to Tyr12 (Figure 2I).
Having established that AAa and AAg can be sulfated in vivo
(albeit as heterogeneous mixtures), we next sought to
investigate the eﬀect of a given tyrosine sulfate modiﬁcation
on thrombin inhibitory activity, which necessitated access to
homogeneously sulfated variants of the anophelins. Toward this
end, we initially envisaged the use of amber-stop codon
suppression,14 a methodology that has been used by Schultz
and co-workers for the production of sulfated hirudin.15,16
Importantly, this technology enables ribosomal incorporation
of sulfated tyrosine at a genetically encoded site using a
mutated tRNA/tRNA synthetase pair and therefore removes
the heterogeneity of enzymatic TPST-catalyzed sulfation
observed in the insect cell expression system. Because in vivo
expression with sulfotyrosine requires unusually high concen-
trations of the unnatural amino acid17 (presumably because of
poor uptake by the cells), we chose to access the sulfated AAa
and AAg through cell-free expression with amber codon
incorporation of the sulfated tyrosine residues at the speciﬁc
sites shown to be sulfated in the baculovirus system. Brieﬂy, AAa
and AAg were expressed in vitro supplemented with sulfotyr-
osine, optimized suppressor-tRNA,18 and puriﬁed sulfotyrosyl-
tRNA synthetase17,19 or polyspeciﬁc p-cyanophenylalanyl-
tRNA synthetase. The anophelin constructs were fused N-
terminally to His6-tagged ubiquitin, which permitted aﬃnity
puriﬁcation of the expressed protein and liberation of the native
sequence through proteolytic cleavage with deubiquitinase20
(see the Supporting Information for methods and character-
ization data). By means of this cell-free expression strategy, a
homogeneous variant of the monosulfated AAg Cfe1 (displaying
sulfation at Tyr12) was generated, together with the truncated
polypeptide in which the ribosomal synthesis stopped at the
amber codon. Cfe1 could be easily separated from the
truncated polypeptide via reversed-phase HPLC to generate
pure monosulfated Cfe1. Unfortunately, attempts to express
doubly sulfated AAa were unsuccessful. Nonetheless, with the
sulfated AAg Cfe1 in hand, we next assessed the eﬀect of
sulfation at Tyr12 on the inhibitory activity against human α-
thrombin by measuring the rate of thrombin-catalyzed cleavage
of the chromogenic substrate Tos-Gly-Pro-Arg-p-nitroanilide in
the presence of Cfe1 (see the Supporting Information).
Importantly, we were able to demonstrate that Cfe1 was a
signiﬁcantly more potent thrombin inhibitor (Ki = 1.13 ± 0.21
pM) than the unsulfated counterpart (Ki = 5.50 ± 1.26 pM),
9
thus validating our hypothesis that sulfation is capable of
modulating the thrombin inhibitory activity of anophelins.
However, as a result of the small quantities of AAg produced
(300 μg from a 10 mL cell-free reaction) coupled with the fact
that in our hands doubly sulfated AAa could not be accessed
through this methodology, we sought an alternative means to
access the entire family of diﬀerentially sulfated variants of the
two proteins. For this purpose, we turned to a chemical
synthesis approach as a means of preparing the entire family of
sulfoforms for both AAa and AAg in suﬃcient quantities for in
depth in vitro and in vivo studies.
Chemical Synthesis of Homogeneously Sulfated AAa
and AAg Proteins. Syn1−Syn4 represented the diﬀerentially
sulfated AAa and AAg targets for chemical synthesis. As both AAa
and AAg exceed the typical polypeptide length limit for
preparation by Fmoc-strategy solid-phase peptide synthesis
(SPPS) (∼40 residues), it was envisioned that these could be
accessed via convergent peptide ligation chemistry. Speciﬁcally,
our synthetic strategy centered on the use of the native
chemical ligation21−desulfurization chemistry that has recently
Scheme 1. Synthesis of Homogeneously Sulfated AAa Variants Syn2−4 via One-Pot Ligation−Desulfurization Chemistry
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been developed for a range of thiol-derived amino acids.22−24
We began by designing a synthetic strategy that would enable
access to the three possible sulfated variants of the 61-residue
AAa. Toward this end, we envisaged disconnection near the
middle of the sequence between Thr30 and Asp31, which
would enable assembly through ligation−desulfurization
chemistry at β-thiol aspartate.25 We conceived that the
sulfoprotein library could be assembled from two N-terminal
peptide thioester fragments (AAa1−30), 5 and 6, with tyrosine
or sulfated tyrosine at Tyr12, respectively, and two C-terminal
fragments (AAa31−61) bearing a β-thiol aspartate25 moiety at
Asp-31 and tyrosine (7) or sulfated tyrosine (8) at Tyr34
(Scheme 1). The (sulfo)peptide fragments 5−8 were readily
synthesized by Fmoc-strategy SPPS and puriﬁed to homoge-
neity via reversed-phase HPLC (see the Supporting Informa-
tion for synthetic details and characterization data).
With the target fragments in hand, the AAa sulfoforms
(Syn2−4) were next assembled using a one-pot ligation−
desulfurization strategy. Speciﬁcally, peptide thioester 5 or
sulfopeptide thioester 6 and β-thiol aspartate-containing
peptide 7 or sulfopeptide 8 were reacted in aqueous denaturing
buﬀer (6 M Gn·HCl, 100 mM Na2HPO4, 10 mM TCEP, pH
7.2) with the addition of triﬂuoroethanethiol (TFET)26 to
accelerate the ligation reactions through the in situ formation of
a C-terminal TFET thioester from the unreactive thioester in 5
and 6. Under these conditions, each of the ligation reactions
was complete within 16 h as judged by HPLC−MS analysis
(see the Supporting Information). Interestingly, the ligation
conditions also resulted in concomitant deprotection of the
neopentyl groups to aﬀord the free tyrosine sulfate esters,
thereby aﬀording the intermediate proteins 9−11. These were
not isolated, but rather, in situ treatment with the water-soluble
radical initiator VA-04424 in the presence of the reductant
TCEP and a hydrogen atom source (reduced glutathione)
eﬀected clean desulfurization of the β-thiol aspartate at the
ligation junction to aﬀord the desired target sulfoproteins
Syn2−4 in crude form. Following a single reversed-phase
HPLC puriﬁcation (using 0.1 M ammonium formate and
acetonitrile as eluents to prevent acidolysis of the fragile
tyrosine sulfate ester13), this one-pot ligation−desulfurization
sequence provided synthetic AAa proteins with sulfation at
Tyr12 (Syn2), Tyr34 (Syn3), and both Tyr12 and 34 (Syn4)
in good yields over the ligation and desulfurization steps.
Having successfully prepared the three possible sulfoforms of
AAa, we next focused on the preparation of the longer (82-
residue) AAg by chemical synthesis, in this case a singly sulfated
variant at Tyr12 (Syn1; vide supra). In this case, the increased
length of the polypeptide required the ligation-based assembly
of three suitably functionalized peptide fragments. We
envisaged that this could be achieved in a one-pot reaction
using a kinetically controlled ligation of three fragments in the
N- to C-terminal direction26,27 followed by in situ desulfuriza-
tion. Speciﬁcally, we chose to disconnect the sequence between
Phe17 and Asp18 and between Thr50 and Ala51. This strategy
gave rise to three target fragments for synthesis: AAg(1−17) 12
bearing a neopentyl-protected sulfate functionality at Tyr12 and
a reactive S-triﬂuoroethyl thioester on the C-terminus, AAg(18−
50) 13 containing a β-thiol aspartate moiety on the N-terminus
and functionalized with an unreactive S-propionate thioester on
the C-terminus, and AAg(51−82) 14 possessing a cysteine
residue in place of the native Ala51 on the N-terminus. Each of
these fragments was successfully prepared via Fmoc-strategy
SPPS (see the Supporting Information for synthetic methods
and characterization). The one-pot synthesis of Syn1 began
Scheme 2. Synthesis of Sulfated AAg Syn1 via a One-Pot Kinetically Controlled Ligation−Desulfurization in the N- to C-
Terminal Direction
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with the chemoselective ligation between reactive sulfopeptide
thioester 12 and bifunctional peptide fragment 13, which was
carried out under standard buﬀer conditions (6 M Gn·HCl, 100
mM Na2HPO4, 10 mM TCEP, pH 6.2) in the absence of an
external thiol additive and reached completion within 5 h as
determined by HPLC−MS to aﬀord ligation product 15
(Scheme 2; see the Supporting Information for the crude data).
It should be noted that the shorter reaction time led to only
partial (25%) loss of the neopentyl ester from the sulfated
tyrosine residue. The ligation product was not isolated at this
stage, but rather, TFET was added to the crude ligation
reaction to activate the unreactive alkyl thioester on the C-
terminus of 15 to generate the reactive S-triﬂuoroethyl
thioester, followed by the addition of fragment 14 bearing an
N-terminal cysteine residue to facilitate native chemical ligation.
In this case, the ligation reaction required 16 h to reach
completion and occurred with concomitant deprotection of all
of the remaining neopentyl ester. All that remained for the
completion of the synthesis was desulfurization of the non-
native β-thiol aspartate and cysteine residues to Asp18 and
Ala51, respectively. The crude reaction mixture was therefore
treated with VA-044, TCEP, and reduced glutathione at 37 °C,
and after 16 h the reaction had reached completion as judged
by HPLC−MS analysis to aﬀord the AAg sulfoprotein Syn1 in
Figure 3. Tyrosine sulfation of AAa and AAg signiﬁcantly improves thrombin inhibition and prolongs blood coagulation in vitro. (A, B) Dose response
curves for the inhibition of α-thrombin activity by increasing concentrations of (A) unsulfated AAa and synthetic sulfated variants Syn2−4 and (B)
recombinant AAg (cE5)9 and synthetic sulfated variant Syn1. (C, D) Dose response curves for the inhibition of γ-thrombin activity by increasing
concentrations of (C) unsulfated AAa and doubly sulfated variant Syn4 and (D) recombinant AAg (cE5)9 and synthetic sulfated variant Syn1. (E)
Inhibition constants (Ki) for A
Aa and AAg sulfoforms, determined by ﬁtting the inhibited steady-state velocity data to the Morrison model. The given
Ki values ± SEM are representative of two independent experiments. Also shown are the thrombin times (TTs), measuring the clotting time of
human plasma in the presence of diﬀerent AAa and AAg sulfoforms (at 5 nM). In the absence of inhibitor, the TT was 21.3 s (mean of four replicates),
and TT values were not evaluated past 140 s. The TT values reported are means of two independent determinations. Errors are depicted as standard
deviations from two independent measurements.
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crude form. It should be noted that in this case the
concentration of VA-044 was reduced (5 mM vs 20 mM for
Syn2−4) to prevent the formation of VA-044 adducts, which
were observed when higher concentrations of the radical
initiator were employed. Following reversed-phase HPLC
puriﬁcation, Syn1 bearing a sulfotyrosine residue at residue
Tyr12 was isolated in 43% isolated yield following the one-pot
process that included two ligations and a double desulfurization
step.
Sulfation Modulates the Thrombin Inhibitory Activity
of the Anophelins. Having successfully prepared sulfated AAg
(Syn1) and the three sulfated variants of AAa (Syn2−4), we
next assessed the in vitro inhibition of human α-thrombin by
the synthetic sulfoproteins to evaluate the eﬀect of tyrosine
sulfation on the activity. The inhibitory potencies of Syn1 and
Syn 4 were also assessed against human γ-thrombin, which has
a disrupted exosite I. Thus, screening against both α- and γ-
thrombin was used to provide an indirect measure of the mode
of binding of the inhibitors to thrombin, i.e., whether the
anophelins may exhibit enhanced exosite II binding when
sulfated.28,29 Inhibition of the amidolytic activities of α- and γ-
thrombin by Syn1−4 was assessed using the kinetic assay
described above by measuring proteolytic cleavage of the
chromogenic substrate Tos-Gly-Pro-Arg-p-nitroanilide (see
Figure 3). As expected, on the basis of the data obtained for
Cfe1, Tyr12 sulfation of AAg in Syn1 led to a mild enhancement
in the thrombin inhibitory activity (Ki = 1.12 ± 0.23 pM)
compared with the unsulfated AAg counterpart (Ki = 5.50 ±
1.26 pM) (Figure 3B,E).9 A more dramatic eﬀect was observed
when sulfation was introduced to AAa in Syn2−4 (Figure 3A,E).
Speciﬁcally, sulfation at Tyr12 in Syn2 led to a 7-fold
improvement in α-thrombin inhibition (Ki = 16.7 ± 1.2 pM
for Syn2 vs Ki = 128.3 ± 2.0 pM for unsulfated A
Aa).
Monosulfation at Tyr34 in Syn3 provided a more pronounced
improvement in activity over the unmodiﬁed AAa (Ki = 7.7 ±
1.1 pM). However, sulfation at both Tyr12 and Tyr34 in Syn4
led to a synergistic improvement in activity with a Ki of 1.7 ±
0.6 pM. Interestingly, while unsulfated AAg and sulfated Syn1
lost 2 and 3 orders of magnitude activity against γ-thrombin
(Figure 3D,E), strongly suggesting an inhibitory mode
involving exosite I binding, unsulfated AAa and doubly sulfated
Syn4 only lost 48−24-fold activity against γ-thrombin (Figure
3C,E). This may suggest that AAa might overcome the decrease
in aﬃnity brought about by the disruption of exosite I by
establishing an additional interaction with exosite II.6 Having
shown that sulfation of the anophelins led to an improvement
in thrombin inhibitory activity in vitro, we next assessed how
the sulfated variants aﬀected the time for thrombin-catalyzed
blood coagulation using a clinical thrombin time (TT) assay.
Gratifyingly, when used at 5 nM concentration, both doubly
sulfated AAa (Syn4, TT = 72.5 s) and sulfated AAg (Syn1, TT ≥
140 s) led to a signiﬁcant increase in thrombin time over the
unmodiﬁed counterparts (37 and 64 s for unmodiﬁed AAa and
AAg, respectively).
Anophelin Sulfoproteins Possess Potent Antithrom-
botic Activity in Vivo. Having shown that sulfation of AAa and
AAg signiﬁcantly improved the thrombin inhibitory potency and
anticoagulant activity in vitro, we next investigated the in vivo
antithrombotic activity of the most potent synthetic variants,
Syn1 and Syn4. We initially conﬁrmed that sulfated AAa and
AAg retained potent inhibitory activity against mouse thrombin
by assessing the impact of these inhibitors on the in vitro mouse
activated partial thromboplastin time (aPTT), a measure of the
time taken for clotting to occur via the intrinsic pathway. Syn1
Figure 4. Eﬀect of thrombin inhibition in vitro and antithrombotic eﬀect of AAa Syn4 and AAg Syn1 in a needle injury thrombus model. (A) Dose
response curves of activated partial thromboplastin time (aPTT) in pooled C57Bl/6 plasma for Syn4 and Syn1. (B, C) Time courses of changes in
(B) platelet thrombus volume and (C) ﬁbrin total ﬂuorescence intensity over 16 min pre- and post-injection of Syn4 (blue) and Syn1 (red). (D)
Representative confocal ﬂuorescence images depicting platelet thrombus and ﬁbrin formation on injured endothelium with no inhibitor, Syn4, and
Syn1. Data points represent mean ± SEM of three to ﬁve independent pooled plasma samples for the aPTT assay and three independent animals
with four to seven injuries each for needle injury experiments, with hirudin as a positive control (see the Supporting Information).
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and Syn4 prolonged the aPTT in a concentration-dependent
manner (Figure 4A) over a similar dose range required to
inhibit human thrombin. To determine the dose requirements
of Syn1 and Syn4 to produce an anticoagulant eﬀect in vivo, we
performed ex vivo aPTT assays on mouse plasma post-i.v.
injection of Syn1, Syn4, or hirudin as a control. Syn1 and Syn4
each prolonged the aPTT in a concentration-dependent
manner (see the Supporting Information). The increase in
aPTT correlated well with the prolongation in tail bleeding
time (see the Supporting Information), conﬁrming the ability
of these peptides to counter the hemostatic function of
thrombin in vivo. On the basis of the ex vivo aPTT data, we
employed therapeutically relevant doses of each inhibitor
(typically a 2−3-fold prolongation of the aPTT, i.e., 25.4 ×
10−2 μmol/kg for AAa Syn4 and 44.3 × 10−2 μmol/kg for AAg
Syn1) to assess their antithrombotic potentials in vivo. For
these studies, we employed a localized needle injury model in
the mesenteric venous circulation of mice that leads to the
formation of highly reproducible mural thrombi composed of
platelets and ﬁbrin, which can be visualized via Alexa 649
αGP1bβ and Alexa 546 αﬁbrin, respectively.30 Treatment with
the doubly sulfated AAa Syn4 and monosulfated AAg Syn1
resulted in major reductions in platelet thrombus volume
(Figure 4B) that coincided with reduced formation of ﬁbrin
polymers (Figure 4C), culminating in signiﬁcant reduction of
the total thrombus size in both treatment groups (Figure 4D;
see the Supporting Information for raw data). Importantly, this
potent in vivo antithrombotic activity of sulfated AAa and AAg
suggests that these molecules may prove useful as leads for the
development of eﬀective direct thrombin inhibitors that operate
through a novel binding mode compared with those currently
used in the clinic. Studies toward this end will be the focus of
future work within our laboratories.
■ DISCUSSION
Hematophagous organisms produce a suite of potent inhibitors
of the blood coagulation cascade to facilitate blood feeding
activities. A number of thrombin-inhibiting peptides and
proteins have recently been identiﬁed in the sialome of a
variety of blood feeders, including leeches, ticks, and ﬂies. Post-
translational modiﬁcations made to these proteins have largely
been overlooked, presumably because of the paucity of material
that can be isolated and characterized from these small
organisms. Previous biochemical characterization of the
mosquito-derived anophelins,6,7 similar to tick salivary
proteins,31 relied on recombinant inhibitors expressed in
prokaryotic systems that do not possess the requisite machinery
to install PTMs speciﬁc to secreted eukaryotic proteins. It is
therefore likely that the thrombin inhibitory activity and, by
extension, the anticoagulant and antithrombotic potency have
been underestimated compared with the activity of the proteins
produced natively in the salivary glands. A key ﬁnding that post-
translational sulfation of tyrosine residues on speciﬁc leech and
tick proteins signiﬁcantly improves the thrombin inhibitory
activity by 1−3 orders of magnitude exempliﬁes the importance
of post-translational modiﬁcations for the modulation of
bioactivity.5,32
Tyrosine sulfation has yet to be observed on salivary proteins
from mosquitoes, a possibility that we explored in this work. A
bioinformatic approach was employed to predict the presence
of this post-translational modiﬁcation on the anophelins, the
thrombin-inhibiting proteins from the Anopheles mosquito.
Expression of an anophelin from the “new-world” mosquito A.
albimanus (AAa) and from the “old-world” mosquito A. gambiae
(AAg) in insect cells followed by nanoLC−MS/MS analysis
unequivocally demonstrated that these proteins can be sulfated
at the predicted tyrosine sites in eukaryotic cells, albeit as
heterogeneous mixtures. Small quantities of pure monosulfated
AAg (Cfe1) could be generated in a cell-free expression system
via amber stop-codon suppression technology, and this material
was used to show that sulfation improved the thrombin
inhibitory activity of the protein. While the cell-free expression
method served as a useful screening tool in this study, the low
yields, coupled with the inability to access AAa bearing two
sulfation sites, led to exploration of an alternative means to
access diﬀerentially sulfated variants of AAa and AAg proteins,
namely, total chemical synthesis. By means of a one-pot native
chemical ligation−desulfurization manifold, the three homoge-
neously sulfated homologues of AAa (Syn2−4) and sulfated AAg
(Syn1) were generated in multimilligram quantities in good
overall yields, enabling the role of sulfation on thrombin
inhibitory and anticoagulant activity to be assessed. Sulfation of
AAa at residues Tyr12 and Tyr34 (Syn4) showed the most
dramatic eﬀect, with a 100-fold increase in thrombin inhibition
(Ki = 1.7 pM), while A
Ag sulfated at Tyr12 (Syn1) led to a 5-
fold improvement in activity (Ki = 1.1 pM). The two sulfated
anophelins showed diﬀering inhibitory activities against γ-
thrombin, which may suggest that the proteins can also
associate with exosite II of thrombin.
Both Syn1 and Syn4 exhibited potent anticoagulant activity
in a clinical thrombin time assay, prolonged aPTT in a dose-
dependent manner ex vivo, and were able to abrogate clot
formation in an in vivo needle injury model of thrombosis.
These results lay the foundation for the study of these
molecules, as well as sulfated anticoagulants from other
bloodfeeders, as novel antithrombotic leads. Indeed, our
ﬁndings now provide the impetus to investigate salivary
proteins from other species of mosquito with a view to
discovering potent bioactive molecules whose activity is
modulated by tyrosine sulfation.
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